Skip to content
Back to news

Servier on the front line of cardiovascular disease prevention and therapeutic adherence

Cardiovascular diseases such as hypertension, coronary artery disease, hypercholesterolemia and heart failure are on the rise worldwide. Faced with this public health challenge, Servier is committed to working alongside patients and health care professionals daily.

High blood pressure and high cholesterol can have serious consequences: heart attack, stroke, sudden death, etc. According to WHO, cardiovascular diseases are responsible for more than 30% of all deaths. With 18.6 million deaths per year(1), this makes them the top cause of death worldwide (excluding communicable diseases). 

This dramatic situation, which worsened during the Covid-19 pandemic, can be explained in particular by the fact that diagnosis and treatment often intervene at too late of a stage. In addition, in spite of the proven effectiveness of medicines, patients suffering from multiple pathologies may not adhere sufficiently to their treatment plans.

Solutions to promote adherence

As a result of the company’s long-standing commitment to the fight against cardiovascular disease, Servier is convinced that adherence is a key issue to address in order to improve patient care

In partnership with leading international scientific societies(2), Servier develops therapeutic solutions suited to the needs of each patient. 

In addition, Servier is working with a number of international patient associations and health care professionals to develop new digital services designed to improve how patients’ illnesses and their care are managed.

A study to improve adherence

Servier strives to encourage engagement between patients and their doctors. To this end, the Group has initiated a project in collaboration with physicians, two patient associations (Global Heart Hub and Senior International Health Association), and institutions such as the European Commission. The first step in this project was to collect observations from patients (over 3,000 across Europe).

“The results from this study will be used to develop a comprehensive digital solution that will allow doctors to provide individualized advice to each patient. We are convinced that this will significantly improve adherence, how hypertension is managed on a global scale and, effectively, the life expectancy of patients,” explains Véronique Morris, Global Medical Communication Lead in hypertension and dyslipidemia at Servier.

Find out more

Partnering to raise public awarenesses

Several global campaigns, co-designed with patient associations, have been launched to raise awareness of the multiple risk factors for cardiovascular disease and the importance of early diagnosis for better care and adherence. 

Servier has supported the International Society of Hypertension’s (ISH) “May Measurement Month” blood pressure screening initiative since 2018. The #BecauseISaySo awareness campaign reinforces this initiative. 

The second part of the #TakeYourMedicine campaign will be launched on September 1 and highlights the importance of following your doctor’s advice and adhering to your prescribed treatment. 

On September 29, for the annual World Heart Day organized by the World Heart Federation (WHF), Servier will support the global cardiovascular risk awareness campaign “USE HEART FOR” as one of the event’s main sponsors. 

Finally, Servier will also launch a new campaign on September 29 to raise public awareness of the importance and urgency of controlling an elevated heart rate from the outset in order to avoid serious complications: Every Beat Matters is based on an emotional approach centered on the patient, as the heart rate should only increase for the right reasons.

Servier at the 2022 ESC Congress in Barcelon

As a historically committed player in cardiology, Servier will participate in the European Society of Cardiology’s (ESC) world congress from August 26 to 29, 2022.

Cardiologists, researchers, care providers, health care industry professionals and scientific experts from around the world will gather to share their latest developments and expertise at the cutting edge of cardiovascular medicine and science.

Servier’s program includes four scientific sessions that will be broadcast live on the event’s digital platform. These sessions will be led by internationally-recognized experts in the fields of coronary heart disease, hypertension, heart failure and hypercholesterolemia